POST-EMBOLISATION
SYNDROME AFTER TACE
Post-embolisation syndrome — the constellation of fever, right upper quadrant pain, nausea, and fatigue following TACE — is not a complication. It is an expected, manageable consequence of tumour ischaemia that occurs in most patients and resolves within 3–7 days with appropriate supportive care.
analyticsAt a Glance
- check_circlePost-embolisation syndrome occurs in 60–90% of TACE patients — it is the rule, not the exception
- check_circleFever (38–39°C), RUQ pain or aching, nausea, and fatigue begin within 4–24 hours and peak at 24–72 hours
- check_circleHospital admission for 1–3 days is standard to manage symptoms with IV fluids, analgesics, and antiemetics
- check_circleSymptoms persisting beyond 7–10 days — or fever above 38.5°C after Day 5 — should trigger investigation for complications
What Is Post-Embolisation Syndrome and Why Does It Occur?
Post-embolisation syndrome (PES) is a systemic inflammatory response triggered by tumour ischaemia and necrosis following TACE. When the hepatic artery feeding the tumour is occluded by embolic material and flooded with chemotherapy, the tumour undergoes rapid necrosis — releasing cellular contents, inflammatory mediators, and cytokines into the systemic circulation.
“Post-embolisation syndrome is the tumour dying. The fever, pain, and malaise are your body's inflammatory response to killing cancer — a sign the treatment has reached its target, not that something has gone wrong.”
Why PES Occurs
Tumour necrosis releases: interleukin-1 and interleukin-6 (causing fever via prostaglandin E2); necrotic cell debris triggering RUQ pain from liver capsule distension; and gut nausea triggers from hepatic nerve stimulation. The intensity of PES generally correlates with the volume of tumour treated — larger tumours and more extensive embolisation produce more pronounced PES.
PES vs TACE Complications: The Critical Distinction
Post-embolisation syndrome is expected and self-limiting. TACE complications (liver abscess, biloma, hepatic artery injury, variceal haemorrhage) are pathological and require medical intervention. The most important patient skill post-TACE is distinguishing expected PES symptoms that can be managed at home or with standard supportive care from warning signs of a serious complication requiring urgent review.
Post-Embolisation Syndrome: Symptom Timeline and Management
A structured reference of PES symptoms, their typical onset and duration, and standard management at each stage.
| Symptom | Onset | Peak | Duration | Management |
|---|---|---|---|---|
| Fever (38–39°C) | 4–24 hours post-TACE | 24–48 hours | 3–7 days | Paracetamol 1g q6h; cool compresses; IV fluids if hydration poor; antibiotics only if bacterial infection suspected (fever >38.5°C after Day 5 with rising CRP) |
| Right upper quadrant pain | 0–12 hours post-TACE | 12–48 hours | 2–5 days | IV morphine or tramadol for initial 24–48 hours; transition to oral codeine + paracetamol; NSAIDs if liver function allows |
| Nausea and vomiting | 0–24 hours | 12–36 hours | 1–3 days | IV ondansetron 8 mg q8h during hospital admission; oral metoclopramide on discharge; clear fluids until nausea resolves |
| Fatigue and malaise | 24–72 hours | 72–96 hours | 7–14 days | Rest during acute phase; encourage light activity from Day 3; fatigue normalises gradually — most patients are near baseline by 2 weeks |
| Appetite loss | 24–72 hours | 72 hours | 5–10 days | Small frequent nutritious meals; high-protein nutritional supplements; avoid fatty foods in first 5 days; hydration is the priority |
| Low-grade fever (37.5–38°C) | May persist for up to 2 weeks | Variable | Up to 14 days | Expected if low-grade — paracetamol; investigate if persistent >38.5°C beyond Day 7 with clinical concern for abscess |
| Elevated liver enzymes (ALT/AST) | Day 1–3 | Day 2–5 | 1–4 weeks normalisation | Expected — monitor; typically return to baseline within 2–4 weeks; significant elevation (>5× baseline) or worsening bilirubin requires hepatology review |
Expected vs Concerning: Recognising Post-TACE Warning Signs
The vast majority of post-TACE symptoms are expected PES. The following signs indicate a potential complication requiring urgent contact with your treating team.
Expected PES — Manageable
- Fever up to 39°C for 3–7 daysPES fever — managed with paracetamol. Report if fever remains above 38.5°C after Day 7 or if rigors (violent shivering) develop.
- Right-sided abdominal aching or heavinessLiver capsule distension from treated tumour swelling — expected. Dull aching managed with analgesics; sharp stabbing pain different from prior discomfort is worth reporting.
- Nausea and reduced appetite for 3–5 daysExpected GI response to embolisation — managed with antiemetics and small frequent meals. Usually resolves by Day 3–5.
- Fatigue lasting 1–2 weeksSystemic inflammatory fatigue — expected. Gradually improving; most patients feel near-normal at 2 weeks.
Seek Medical Attention
- Fever above 38.5°C after Day 5 with rigors or worsening painMay indicate liver abscess — a serious complication requiring urgent CT evaluation, blood cultures, and broad-spectrum antibiotics.
- Worsening RUQ pain with jaundice after Day 5Biloma or bile leak from chemobiliary injury — requires urgent imaging. Jaundice may also indicate liver decompensation.
- Sudden severe abdominal painMay indicate haemorrhage from hepatic artery pseudoaneurysm or gallbladder necrosis — urgent emergency evaluation required.
- Progressive yellowing (jaundice) or confusionSigns of acute liver decompensation — post-TACE liver failure in patients with borderline liver function. Urgent hepatology review.
- Groin haematoma or pulsatile swelling at femoral access siteFemoral pseudoaneurysm or haematoma — requires vascular surgery evaluation if expanding or pulsatile.
Post-TACE Recovery: A Week-by-Week Timeline
Understanding the expected recovery trajectory helps patients and families plan realistically.
- 1
Day 0–1 (In Hospital): Acute Phase
IV fluids, analgesics, antiemetics, and monitoring are the priorities. Most patients are alert but uncomfortable — pain is managed and fever treated. A post-procedure ultrasound may check for haematoma at the access site.
- 2
Day 1–3 (In Hospital): Peak PES
Fever, pain, and nausea typically peak in the first 48–72 hours. IV medication transitions to oral once the patient can tolerate fluids. Liver enzymes and bilirubin are checked on Day 2–3 to monitor hepatic stress response.
- 3
Day 3–5 (Discharge to Home): Transition
Most patients are discharged Day 2–4 on oral analgesics, antiemetics, and temperature monitoring instructions. Fever should be declining; pain should be manageable with oral paracetamol ± codeine. Rest and adequate hydration are the priorities.
- 4
Week 1–2 (At Home): Gradual Recovery
Fatigue decreases progressively. Appetite returns. Fever resolves by Day 7–10 in most patients. Light walking is encouraged from Day 3; driving is not recommended for 5–7 days; heavy lifting or strenuous activity should wait 2 weeks.
- 5
Week 4–6 (First Follow-Up Imaging)
Contrast-enhanced MRI or CT confirms TACE response. The imaging will typically show a larger treated area than the original tumour — the safety margin of ablation. This is normal and expected. The absence of arterial enhancement in the treated zone confirms successful necrosis.
TACE Complications: Type, Frequency, and Management
Beyond post-embolisation syndrome, the following represent true TACE complications — distinguishable from PES by their timing, severity, and clinical pattern.
| Complication | Frequency | Typical Presentation | Management |
|---|---|---|---|
| Liver abscess | 1–2% | Fever >38.5°C beyond Day 5; worsening RUQ pain; leucocytosis; confirmed on CT as ring-enhancing fluid collection | Percutaneous aspiration ± drainage; IV broad-spectrum antibiotics; prolonged treatment 4–6 weeks |
| Biloma / bile duct injury | 0.5–1% | Persistent RUQ pain; cholangitis features; CT shows peri-biliary fluid collection | Percutaneous drainage; antibiotics; ERCP stent if biliary obstruction |
| Acute liver decompensation | 1–3% | Worsening jaundice; encephalopathy; ascites increase post-TACE; most common in Child-Pugh B patients | Supportive hepatology care; transfusions; lactulose; consider transplant listing escalation if relevant |
| Hepatic artery injury | 0.5–1% | Pseudoaneurysm or dissection; RUQ pain post-procedure; confirmed on CT angiography | Interventional radiology re-intervention; coil embolisation of pseudoaneurysm |
| Non-target embolisation | Rare (<0.5%) | Splenic, gastric, or bowel ischaemia; pain in non-hepatic location; imaging confirms | Depends on territory — conservative for splenic; surgical consultation for bowel involvement |
| Variceal haemorrhage | 1% | Haematemesis post-TACE in patients with portal hypertension; TACE reduces portal pressure reserve | Emergency endoscopy; variceal banding; octreotide; avoid TACE in patients with high-risk varices |
More from the TACE Resource Library
Continue exploring TACE — from technique selection and eligibility to combination strategies and access.
- What Is TACE? A Patient Introduction to Liver Cancer Embolisation
- TACE Patient Selection: BCLC Staging and Child-Pugh Score
- cTACE vs DEB-TACE: Which Technique Is Right for Your HCC?
- TACE Survival Data: Evidence from Pivotal Clinical Trials
- TACE as Bridge to Liver Transplant: How It Works
- TACE Therapy — Complete Treatment Guide
Frequently Asked Questions
Common questions from patients experiencing post-embolisation syndrome after TACE.
About Post-Embolisation Syndrome
I have a fever of 38.5°C four days after TACE — is this normal or should I go to hospital?
At Day 4 post-TACE, a fever of 38.5°C is in the borderline zone between expected PES (which typically peaks at Days 1–3) and early-phase resolution that might justify hospital review. Key questions: Is the fever rising or falling compared to yesterday? Is the RUQ pain worsening or improving? Do you feel specifically unwell — rigors (violent shaking), chills, feeling systemically very unwell beyond the expected PES level? If fever is falling day-on-day and you feel gradually better overall, continued monitoring with paracetamol is reasonable. If fever is rising, you have developed rigors, or RUQ pain is worsening, contact your treating centre for same-day clinical assessment — early detection of liver abscess is significantly better than waiting until it is well-established.
How long will the fatigue last after TACE?
Post-TACE fatigue is one of the most underestimated aspects of recovery. Most patients feel significantly better at 2 weeks, but full energy recovery often takes 3–4 weeks after a significant TACE session. Factors that prolong fatigue: larger tumours treated (more ischaemia and necrosis), multiple embolised vessels, poor nutritional status, and cumulative fatigue from prior TACE sessions. The fatigue is physical — from the inflammatory response and the liver's metabolic stress — and is not a sign of treatment failure or disease progression. Protein-adequate nutrition, light daily activity from Day 3–5, and good sleep are the most effective recovery strategies. If fatigue is not improving after 3 weeks or is worsening after initial improvement, discuss with your hepatologist to exclude anaemia, liver decompensation, or depression as contributing factors.
Can I eat normally while recovering from TACE?
In the first 24–48 hours, clear fluids and light easily digestible foods are recommended — crackers, dry toast, soup, yoghurt. The liver is handling significant inflammatory load and the GI tract is dealing with nausea from embolisation. From Day 3 onwards, progress to a soft and then normal diet as appetite returns. Avoid fatty, fried, or very spicy foods for the first week — these increase biliary workload at a time when the liver's functional capacity is temporarily reduced. Adequate protein intake (chicken, fish, eggs, legumes) is important from early recovery — the liver uses amino acids for regeneration and the inflammatory response. A dietitian consultation is valuable if appetite loss persists beyond 5 days post-TACE.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Planning for Recovery After TACE?
CancerFax coordinates the complete TACE treatment experience — including post-procedure monitoring, recovery support at Chinese and Indian centres, and remote follow-up after you return home.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.